Inventor · disambiguated record
Brad St. Croix
Also filed as: ST CROIX BRAD
17 granted patents·6 pending applications·96 citations·filing 2001–2020
91Inventor score
Files withBIOMED VALLEY DISCOVERIES INC8ST CROIX BRAD4UNIV JOHNS HOPKINS4US HEALTH4FRANKEL ARTHUR E1
Top patents by PatentIndex Score
23 records- 0196US9765142B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2014·Granted Sep 19, 2017·31 cites·49 claims
- 0291US7358351B2Endothelial cell expression patternsUNIV JOHNS HOPKINS·Filed 2004·Granted Apr 15, 2008·32 cites·20 claims
- 0386US10758614B2Combination therapies targeting tumor-associated stroma or tumor cells and topoisomeraseBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·3 cites·10 claims
- 0479US7402660B2Endothelial cell expression patternsUNIV JOHNS HOPKINS·Filed 2001·Granted Jul 22, 2008·9 cites·32 claims
- 0578US9309322B2Antibodies to tumor endothelial marker 8FRANKEL ARTHUR E·Filed 2011·Granted Apr 12, 2016·2 cites·6 claims
- 0678US7393932B2Endothelial cell expression patternsUNIV JOHNS HOPKINS·Filed 2002·Granted Jul 1, 2008·14 cites·27 claims
- 0773US9181340B2TEM8 antibodies, conjugates thereof, and their useST CROIX BRAD·Filed 2012·Granted Nov 10, 2015·5 cites·37 claims
- 0862US2013202528A1Differential gene expression in physiological and pathological angiogenesisREPRESENTED BY THE SECRETARY OF THE DEPARTME THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS·Filed 2013·Application pending·0 cites
- 0960US10196443B2TEM8 antibodies and their use in treatment and detection of tumorsUS HEALTH·Filed 2017·Granted Feb 5, 2019·0 cites·33 claims
- 1060US2011104059A1Membrane Associated Tumor Endothelium MarkersUNIV JOHNS HOPKINS·Filed 2009·Application pending·0 cites
- 1155US8440411B2Differential gene expression in physiological and pathological angiogenesisST CROIX BRAD·Filed 2011·Granted May 14, 2013·0 cites·8 claims
- 1255US2016194720A1Differential gene expression in physiological and pathological angiogenesisUS HEALTH·Filed 2015·Application pending·0 cites
- 1354US10273299B2Antibodies to tumor endothelial marker 8SCOTT & WHITE HEALTHCARE·Filed 2016·Granted Apr 30, 2019·0 cites·23 claims
- 1454US2010028256A1Differential gene expression in physiological and pathological angiogenesisST CROIX BRAD·Filed 2007·Application pending·0 cites
- 1551US2023032465A1Antibody-drug conjugates specific for cd276 and uses thereofUS HEALTH·Filed 2020·Application pending·0 cites
- 1645US10799584B2Combination therapies using agents that target tumor-associated stroma or tumor cells and alkylating agentsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 13, 2020·0 cites·6 claims
- 1744US11033620B2Combination therapies targeting tumor-associated stroma or tumor cells and microtubulesBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·13 claims
- 1844US10758613B2Combination therapies using anti-metabolites and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 1943US11034757B2Combination therapies using agents that target tumor-associated stroma or tumor cells and tumor vasculatureBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·6 claims
- 2043US2009233270A9Secreted and cytoplasmic tumor endothelial markersST CROIX BRAD·Filed 2003·Application pending·0 cites
- 2142US10758526B2Combination therapies using agents that target tumor-associated stroma or tumor cells and other pathwaysBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Sep 1, 2020·0 cites·11 claims
- 2240US11033621B2Combination therapies targeting tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Jun 15, 2021·0 cites·12 claims
- 2339US10434174B2Combination therapies using platinum agents and agents that target tumor-associated stroma or tumor cellsBIOMED VALLEY DISCOVERIES INC·Filed 2015·Granted Oct 8, 2019·0 cites·37 claims
Join the waitlist — get patent alerts
Get an alert when Brad St. Croix files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →